Obesity
Conference Coverage
More STEP data: Semaglutide cuts weight, cravings, beats liraglutide
In STEP 5, weight loss with semaglutide was sustained at 2 years and the drug cut cravings in a subgroup; in STEP 8, semaglutide beat liraglutide...
Conference Coverage
Liraglutide effective against weight regain after gastric bypass
In a randomized controlled trial of patients who regained weight after a gastric bypass, 69% of patients given liraglutide lost at least 5% of...
Conference Coverage
‘If obesity were diabetes or cancer, how would you approach it?’
There’s so much misinformation about obesity, says an expert. ‘People think it’s a lack of willpower, and even patients blame themselves for not...
From the Journals
AHA dietary guidance cites structural challenges to heart-healthy patterns
The American Heart Association urges Americans to protect their health through better nutrition, while recognizing the numerous obstacles that...
Opinion
Time to attack hypoactivity in our children
Our sedentary lifestyles are shortening our lives and launching our children into adulthood burdened with a raft of health risks they could...
From the Journals
Neighborhood fast food restaurants linked to type 2 diabetes
“Neighborhood food environment was associated with type 2 diabetes risk among U.S. veterans in multiple community types, suggesting potential...
From the Journals
‘Green’ Mediterranean diet benefits may arise from ‘hunger hormone’
Greater increases in fasting ghrelin associated with improved metabolic benefits seen with plant-enhanced Mediterranean diet. But one commentator...
Latest News
Why kids might reject sugar-free Halloween candy
A study showed that there are two pathways for tasting sweet things: one for tasting sweetness and one for tasting caloric content.
From the Journals
SURPASS-4: ‘Twincretin’ tirzepatide surpasses insulin glargine in pivotal trial
Tirzepatide, a single-molecule, dual receptor agonist, maintained its pivotal-trial win streak in its fifth and final randomized test before...
From the Journals
Researchers parse which patients with T2D need SGLT2 inhibition
From the Journals
To tackle obesity, up fitness and activity or lose weight?
Researchers promote a ‘weight-neutral approach to treating obesity-related health conditions.’